Please wait

 

Exhibit 107

Calculation of Filing Fee Tables

FORM S-3

(Form Type)

MEI Pharma, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities and Carry Forward Securities

 

 

Security

Type

Security
Class
Title

Fee
Calculation
or Carry
Forward Rule

Amount
Registered

Proposed
Maximum
Offering Price
Per Unit

Maximum
Aggregate
Offering Price

Fee Rate

Amount of
Registration Fee

Carry

Forward

Form

Type

Carry

Forward

File

Number

Carry

Forward

Initial

Effective

date

Filing Fee

Previously

Paid In

Connection

with Unsold

Securities to

be Carried

Forward

Newly Registered Securities

Fees to Be Paid

Equity

Common Stock, par value $0.00000002 per share

457(o)

(1)

(2)

(2)

N/A

N/A

 

 

 

 

 

Equity

Preferred Stock, par value $0.01 per share

457(o)

(1)

(2)

(2)

N/A

N/A

 

 

 

 

 

Other

Warrants

457(o)

(1)

(2)

(2)

N/A

N/A

 

 

 

 

 

Other

Rights

457(o)

(1)

(2)

(2)

N/A

N/A

 

 

 

 

 

Other

Units

457(o)

(1)

(2)

(2)

N/A

N/A

 

 

 

 

 

Unallocated (Universal) Shelf

(1)

457(o)

(1)

(2)

$100,000,000

0.0001476

$14,760

 

 

 

 

Fees Previously Paid

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Carry Forward Securities

Carry Forward Securities

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Offering Amount

 

$100,000,000

 

$14,760

 

 

 

 

 

Total Fees Previously Paid

 

 

 

-

 

 

 

 

 

Total Fee Offsets

 

 

 

$13,949.21 (3)

 

 

 

 

 

Net Fee Due

 

 

 

$810.79

 

 

 

 

 

 

 

(1)
The securities registered hereunder may be sold separately, together or as units with the other securities registered hereunder. The securities registered hereunder also include such indeterminate number of shares of common stock and preferred stock as may be issued upon conversion of or exchange for preferred stock that provide for conversion or exchange, upon exercise of warrants or pursuant to the anti-dilution provisions of any of such securities. In addition, pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the securities being registered hereunder include such indeterminate number of shares of common stock and preferred stock as may be issuable with respect to the securities being registered hereunder as a result of stock splits, stock dividends or in connection with a stock combination, recapitalization, merger, consolidation or otherwise.
(2)
The proposed maximum per unit and aggregate offering prices per class of securities will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered under this registration statement and is not specified as to each class of security pursuant to Instruction 2.A.iii.b. to the Calculation of Filing Fee Tables and Related Disclosure on Form S-3 under the Securities Act.
(3)
Please see Table 2 below.

Table 2: Fee Offset Claims and Sources

 

 

      Registrant or
F Filer Name

Form or
Filing Type

File
Number

Initial
Filing Date

Filing Date

Fee Offset
Claimed

Security Type
Associated with
Fee Offset

Claimed

Security Title
Associated with
Fee Offset

Claimed

Unsold
Securities
Associated with
Fee Offset

Claimed

Unsold Aggregate
Offering Amount
Associated with
Fee Offset

Claimed

Fee Paid with
Fee Offset Source

Rule 457(p)

Fee Offset Claims

MEI Pharma, Inc.

S-3 (4)

333-238056

May 5, 2020

 

$13,949.21

(5)

(5)

(5)

$107,466,957 (6)

 

Fees Offset Sources

MEI Pharma, Inc.

S-3 (4)

333-238056

 

May 5, 2020

 

 

 

 

 

$13,949.21

 

(4)
The registrant has either withdrawn each prior registration statement or has terminated or completed any offering that included the unsold securities under the prior registration statement.
(5)
The securities offered thereunder included up to $200,000,000 aggregate initial offering price of such indeterminate number of shares of common stock and preferred stock and such indeterminate number of warrants to purchase common stock or preferred stock.
(6)
Pursuant to Rule 415(a)(6) under the Securities Act, the registrant included $107,466,957 of newly registered securities thereunder for which the filing fee of $13,949.21 was paid.